If Gilead does not partner with cydy instead of hoping they go away, once Cydy finally gets money for all these indications and get approvals for combo and mono, I could imagine some very angry shareholders of Gilead as CYDY takes their market and then expands into cancer, autoimmune, stroke, heart, etc. Its not like they are unaware at this point. Almost, every Gilead SA article turns into a talk about cydy at some point. And NP stating words from Gilead’s own analysts saying the same thing.